cas 1159977-56-6|| where to buy 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindoline-2,3-dione

Product Name:5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindoline-2,3-dione

IUPAC Name:5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1H-indole-2,3-dione

Packing Unit	Available Stock	Price($)
CM148361-250mg	in stock	ȦǲƱ
CM148361-1g	1-2 Weeks	ƱƻƱſ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1159977-56-6 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:1159977-56-6; Molecular Formula:C21H19ClN4O2S; Melting Point:-; Smiles Code:O=C1NC2=C(C=C(CCN3CCN(C4=NSC5=CC=CC=C45)CC3)C(Cl)=C2)C1=O; Density:

: Catalog Number:CM148361; Molecular Weight:426.92; Boiling Point:; MDL No:; Storage:Store at 2-8°C.

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.

: Benzoisothiazoles; Benzoisothiazole is a benzo derivative of isothiazole, which is a kind of bicyclic aromatic organic compound, which is formed by fusion of a six-membered benzene ring and a five-membered heterocyclic ring composed of two adjacent heteroatoms, N and S. Benzoisothiazoles are important pharmaceutical intermediates. Some benzoisothiazole derivatives exhibit potent cytotoxic and antitumor activities.

: Indolinediones; 2,3-Indolinedione derivatives have been identified as a novel class of promising agents for cancer treatment.